CClinicalTrials.gg
CompletedNCT01798524KAREUpdated Feb 26, 2013

Kidney Allograft Recipients in England - an Observational Cohort Study

An observational study in Kidney Transplantation, sponsored by University Hospital Birmingham NHS Foundation Trust. Completed at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2013-02-26.

Sponsored by University Hospital Birmingham NHS Foundation Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
19,688
Sex
All
01

Study summary

Kidney transplantation is the renal replacement therapy of choice for the majority of patients with end-stage kidney disease. Epidemiological studies of kidney allograft recipients can aid in the understanding of cause and effect of health and disease post-transplantation. The combination of health care and information technology has made the potential of transplant professionals to use health information effectively crucial to guide kidney transplant management. The aim of this study is to undertake an observational cohort study of kidney allograft recipients, supported by linking analysis across different database sources, to provide a comprehensive biomedical dataset of information.

02

Conditions studied

  • Kidney Transplantation

Keywords

  • Transplant
  • Kidney
  • England
03

In context

Lead sponsor

University Hospital Birmingham NHS Foundation Trust is the lead sponsor of 35 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All kidney allograft recipients transplanted at an English transplant centre between April 2001 and March 2012

Inclusion criteria

  • Kidney transplant alone
  • English Transplant centre
  • All ages
  • Kidney allograft receipt between April 2001 and March 2012

Exclusion criteria

Exclusion Criteria:

  • Multiple organ transplant
  • Transplant performed at non-English centre
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
19,688 participants (actual)
Patient registry
No

Groups and cohorts

  • Kidney allograft recipients
06

What researchers measure

Primary outcomes

  1. Mortality within the first year post kidney transplantation

    Time frame: One year

Secondary outcomes

  1. Mortality beyond the first year post kidney transplantation

    Time frame: Up to 12 years

07

Study locations

1 site
  • University Hospitals Birmingham NHS Foundation trust
    Birmingham, B15 2WB, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01798524
Lead sponsor
University Hospital Birmingham NHS Foundation Trust
Responsible party
Adnan Sharif (Dr, University Hospital Birmingham NHS Foundation Trust) — Principal investigator
First posted
Feb 26, 2013
Start date
Nov 2011
Primary completion
Feb 2013
Last update
Feb 26, 2013

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion